Abstract
Beta blockers (BB) are selective and competitive antagonists of beta adrenergic receptors. They oppose with their action, to the stimulant effect of the sympathoadrenergic system. Since the differentiation of alpha and beta adrenergic receptors by Alhquist [1], pharmacologists have not ceased to create agonist molecules or increasingly selective antagonists. These molecules are designed to produce the desired action with the least possible secondary effect.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahlquist RP (1948) A study of adrenotropic receptors. Am J Physiol 153: 586–600
Piriou V, Aouifi A, Lehot JJ (2000) Intérêt des bêta-bloquants en médecine périopératoire. Can J Anaesth 7: 653–663
Jones KG, Powell JT (2000) Slowing the heart saves lives: advantages of perioperative ß blockade. Br J Surg 84: 689–690
Roysler RL (2002) Perioperative beta-blockade can reduce morbidity and mortality. APSF Newslett 17: 21–23
Raby KE, Brull SJ, Timimi F et al (1999) The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 88: 477–482
Coloma M, Chiu JW, White PF, Armbruster SC (2001) The use of esmolol as an alternative to remifentanil during desflurane anesthesia for fast-track outpatient gynecologic laparoscopic surgery. Anesth Analg 92: 352–357
Johansen JW, Schneider G, Windsor AM, Sebel PS (1998) Esmolol potentiates reduction of minimum alveolar isoflurane concentration by alfentanil. Anesth Analg 87: 671–676
Moniotte S, Kobazik L, Feron O et al (2001) Up regulation of b3 adrenoceptors and altered contractility response to inotropic amines in human failing myocardium. Circulation 103: 1649–1655
Zaugg M, Schaub MC, Pasch T, Sphan DR (2002) Modulation of ß adrenergic receptors subtype activities in perioperative medicine: mechanisms and sites of actions. Br J Anaesth 88: 101–123
Gheorghiade M, Colucci S, Swedelberg K (2003) B Blockers in chronic heart failure. Circulation 107: 1570–1575
Peterzen B, Lonn U, Babi’c A et al (1999) Anesthetic management of patients undergoing coronary artery bypass grafting with the use of an axial flow pump and a short-acting beta-blocker. J Cardiothorac Vasc Anesth 13: 431–436
Poldermans D, Boeresma E, Bax JJ et al (1999) The effect of bispropolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341: 1789–1794
Auerbach AD, Goldamn L (2002) Beta blockers and reduction of cardiac events in non cardiac surgery. JAMA 287: 1435–1444
Angeja BG, Grossman W (2003) Evaluation and management of diastolic heart failure. Circulation 107: 659–663
Vasan RS, Benjamin EJ (2001) Diastolic heart failure — no time to relax. N Engl J Med 1: 56–58
Kim MH, Devlin H, Das SK et al (1999) Effect of ß adrenergic blocking therapy on left ventricular diastolic relaxation proprieties in patients with dilated cardiomiopathy. Circulation 100: 729–735
Nagatsu M, Spinale FG, Koide M et al (2000) Bradycardia and the role of ß blockade in the amelioration of left ventricle dysfunction. Circulation 101: 653–659
Lechat P, Hulot JS, Escolamo S et al (2001) Heart rate and cardiac rhythm relationships with bispropolol benefit in chronic heart failure in CIBIS II trial. Circulation 103: 1428–1433
Landesburg G, Zhou W, Aversano T (1999) Tachycardia—induced subendocardial necrosis in acutely instrumented dogs with fixed coronary stenosis. Anesth Analg 88: 973–979
Pasternack PF, Imparato AM, Bauman FG et al (1987) The hemodynamics of beta blockade in patient undergoing abdominal aortic aneurysm repair. Circulation 76 (Suppl III): 1–7
Fita G, Gomar C, Rovira I (1999) Esmolol en anestesiologfa: farmacologfa e indicaciones. Rev Esp Anestesiol Reanim 46: 404–414
Grossman W (2000) Defining diastolic dysfunction. Circulation 101: 2020–2021
Banerjee P, Banerjee T, Khand A et al (2002) Diastolic heart failure: neglected or misdiagnosed? J Am Coll Cardiol 39: 138–141
Zile MR, Brutsaert DL (2002) New concepts in diastolic dysfunction and diastolic heart failure: part I. Circulation 105: 1387–1393
Zile MR, Brutsaert DL (2002) New concepts in diastolic dysfunction and diastolic heart failure: part II. Circulation 105: 1503–1508
Bristow MR (1997) Mechanism of action of beta-blocking agents in heart failure. Am J Cardiol 80: 26L - 40L
Krum H (1999) ß blockers in heart failure. The “new wave” of clinical trials. Drugs 58: 203–210
Muchada R (2002) Cardio beta modulation with dobutamine — esmolol simultaneous perfusion. Anesthesiology 96: A635
Muchada R (1999) Non invasive hemodynamic diagnostic of hyperkinetic septic shock treated with 13 blocker. Intensive Care Med 25 Suppl 1: 142
Shakar SF, Abrham WT, Gilbert EM et al (1998) Combined oral positive inotropic and 13 blockers therapy for treatment of refractory class VI heart failure. J Am Coll Cardiol 31: 1336–1340
Bristow MR, Shakar SF, Linseman JV et al (2001) Inotropes and 13—blockers: is there a need for new guidelines? J Cardiac Failure 72 (Suppl 1): 8–12
Bristow M (2003) Antiadrenergic therapy of chronic heart failure. Surprises and new opportunities. Circulation 107: 1100–1102
Magnano DT, Layug EL, Wallace A et al (1996) Effect of atenolol on mortality and morbidity after non cardiac surgery. Multicenter study of perioperative research group. N Engl J Med 335: 1713–1720
Harwood TN, Butterworth J, Prielipp RC et al (1999) The safety and the effectiveness of esmolol in the perioperative period in patients undergoing abdominal aortic surgery. J Cardiothorac Vasc Anesth 13: 555–561
Frishman WH, Cheng A (1999) Secondary prevention of myocardial infarction: role of beta adrenergic blockers and angiotensin converting enzyme inhibitors. Am Heart J 137: S25 - S34
Palatini P, Casaglia E, Julius S, Pessina AC (1999) High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med 159: 585–592
Barbier GH, Shettigar UR, Appunn DO (1995) Clinical rationale for the use of an ultra short acting beta-blocker; esmolol. Int J Clin Pharmacol Ther 33: 212–218
Leug JM, Manku K (2000) Prophylactic therapy of preoperative myocardial ischemia. Curr Anesthesiol Rep 2: 77–85
Howell SJ, Sear JW, Foex P (2001) Peri-operative 13-blockade a useful treatment that should be greeted with cautious enthusiasm. Br J Anaesth 2: 161–164
Kleiman B (2002) Perioperative beta-blockade requires further study — not standard of care. APSF Newslett 17: 55
Manigaux C, Guignard B, Adam F et al (2002) Esmolol prevent movement and attenuates BIS response to orotracheal intubation. Br J Anaesth 89: 857–862
Than PH, Yang LC, Shih HC et al (2002) Combined use of esmolol and nicardipine to blunt the haemodynamic changes following laryngoscopy and tracheal intubation. Anaesthesia 57: 1195–1212
Scott DB, Buckley FP, Drumond GB et al (1978) Cardiovascular effect of labetalol during halothane anaesthesia. Br J Anaesth 3 (Suppl): 817–821
Edmonson R, Del Valle O, Sha N et al (1989) Esmolol for potation of nitroprusside-induced hypotension: impact on the cardiovascular adrenergic and rening angiotensin systems in men. Anesth Analg 69: 202–206
Gold MI, Sacks DJ, Grosnoff DB et al (1989) Use of esmolol during anesthesia to treat tachycardia and hypertension. Anesth Analg 68: 104–104
Seltzer JL, Ritter DE, Starsnic MA, Man AT (1985) The hemodynamic response to traction on the abdominal mesentery. Anesthesiology 63: 96–99
Muchada R (2001) Mesure du débit aortique par méthode non invasive. In: Dalens B (ed) Traité d’anesthésie générale, vol 4. Arnette, Rueil-Malmaison, pp 2–18
Peterson GE, Brickner E, Reimold SC (2003) Transesophageal echocardiography. Clinical indications and applications. Circulation 107: 2398–2402
Askenazi J, MacCosbe PE, Hoff J et al (1987) Hemodynamic effects of esmolol, an ultrashortacting beta blocker. J Clin Pharmacol 27: 567–573
Buffington CW (1985) Hemodynamic determinants of ischemia myocardial disfunction. Aneshtesiology 63: 655–662
Menkaus PG, Reyes JG, Kissing Yet al (1985) Cardiovascular effects of esmolol in anesthetized humans. Anesth Analg 64: 327–334
Reilly CS, Wood M, Kosakii RP, Wood AJ (1985) Ultra-short-acting-blockade: a comparison with conventional beta-blockade. Clin Pharmacol Ther 38: 579–585
Sasao J, Tarver SD, Kindscher JM et al (2001) In rabbits, landiolol, a new ultra-short-acting ß-blocker exert more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anaesth 48: 985–989
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Italia, Milano
About this paper
Cite this paper
Muchada, R. (2004). Perioperative b-adrenergic blocking drugs: from concept to applications. In: Gullo, A. (eds) Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.. Springer, Milano. https://doi.org/10.1007/978-88-470-2189-1_7
Download citation
DOI: https://doi.org/10.1007/978-88-470-2189-1_7
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0235-7
Online ISBN: 978-88-470-2189-1
eBook Packages: Springer Book Archive